Dhaka, May 3 -- Renata PLC has reported a 13.20 per cent growth in revenue, reaching Tk3,132.85 crore in the first nine months of the current fiscal year 2024-25. This growth was primarily driven by increased demand volume, while the prices of pharmaceutical products remained unchanged.While its pharmaceuticals' revenue grew by 15.5 per cent, animal health and contract manufacturing declined by 19.6 per cent and 31.9 per cent, respectively, according to its un-audited financial statement.Also, its export revenue grew by 22.5 per cent across in 57 countries. However, despite the growth in revenue and exports, its net year-on-year profit declined by 30.5 per cent to Tk183.9 crore, down from Tk263.2 crore in the same time of the previous fis...